These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 6734921

  • 1. Oral buflomedil in diabetic background retinopathy: results of a preliminary controlled study.
    Ducrey N, Curchod B.
    J Int Med Res; 1984; 12(3):184-7. PubMed ID: 6734921
    [Abstract] [Full Text] [Related]

  • 2. The effect of buflomedil in diabetic retinopathy estimated by ocular fluorophotometry.
    Kjaergaard JJ, Ditzel J.
    Int J Microcirc Clin Exp; 1987 Aug; 6(3):257-63. PubMed ID: 3308731
    [Abstract] [Full Text] [Related]

  • 3. Double-blind placebo-controlled trial of buflomedil in the treatment of Raynaud's phenomenon: six-month follow-up.
    Le Quentrec P, Lefebvre ML.
    Angiology; 1991 Apr; 42(4):289-95. PubMed ID: 1673051
    [Abstract] [Full Text] [Related]

  • 4. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G, Balzer K, Bisler H, Klüken N, Muller-Wiefel H, Unkel B, Mahfoud Y, Ziegler W.
    Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
    [Abstract] [Full Text] [Related]

  • 5. Effect of buflomedil on behaviour, memory, and intellectual capacity in patients with dementia. A placebo-controlled study.
    Levinson B, Wright P, Barklem S.
    S Afr Med J; 1985 Aug 31; 68(5):302-7. PubMed ID: 3898413
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of sorbinil on blood-retinal barrier in early diabetic retinopathy.
    Cunha-Vaz JG, Mota CC, Leite EC, Abreu JR, Ruas MA.
    Diabetes; 1986 May 31; 35(5):574-8. PubMed ID: 3514333
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
    Van den Brande P, Maurel A.
    Angiology; 1998 Feb 31; 49(2):105-14. PubMed ID: 9482510
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial.
    Scott IU, Jackson GR, Quillen DA, Larsen M, Klein R, Liao J, Holfort S, Munch IC, Gardner TW.
    JAMA Ophthalmol; 2014 May 31; 132(5):535-43. PubMed ID: 24604308
    [Abstract] [Full Text] [Related]

  • 12. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L, Gandolfo AM, Utz C.
    MMW Munch Med Wochenschr; 1984 Mar 02; 126(9):247-8. PubMed ID: 6425678
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The pharmacological effects of buflomedil in patients with multi-cerebral infarcts dementia: an open, preliminary assessment.
    Karoutas G, Milonas I, Artemis N, Karacostas D, Pitas J, Logothetis J.
    Curr Med Res Opin; 1987 Mar 02; 10(6):380-9. PubMed ID: 3568750
    [Abstract] [Full Text] [Related]

  • 15. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.
    Int Angiol; 2001 Dec 02; 20(4):337-44. PubMed ID: 11782701
    [Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of the activity of buflomedil in ischemic processes in the legs].
    Savagnone E, Sunseri V.
    Minerva Cardioangiol; 1985 Nov 02; 33(11):757-64. PubMed ID: 4088478
    [No Abstract] [Full Text] [Related]

  • 17. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 18. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F, Meites G, Rousseau H, Staffin C, Allaert FA, Pelat P.
    Ann Radiol (Paris); 1994 Feb 12; 37(3):239-44. PubMed ID: 8092756
    [Abstract] [Full Text] [Related]

  • 19. [Naftidrofuryl in the treatment of simple diabetic retinopathy. A double-blind study].
    Klein M, Hirche H.
    Klin Monbl Augenheilkd; 1985 Sep 12; 187(3):195-201. PubMed ID: 3906248
    [Abstract] [Full Text] [Related]

  • 20. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G, Balzer K, Bisler H, Klüken N, Mahfoud Y, Müller-Wiefel H, Unkel B, Ziegler W.
    Dtsch Med Wochenschr; 1982 Dec 24; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.